INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 29 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $414,000 | +43.8% | 1,460,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $288,000 | -60.5% | 1,460,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $730,000 | -31.4% | 1,460,000 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $1,064,000 | -85.6% | 1,460,000 | -14.1% | 0.00% | -83.3% |
| Q2 2019 | $7,378,000 | -40.8% | 1,700,000 | 0.0% | 0.02% | -41.9% |
| Q1 2019 | $12,461,000 | -2.8% | 1,700,000 | 0.0% | 0.03% | -13.9% |
| Q4 2018 | $12,818,000 | +12.0% | 1,700,000 | -16.0% | 0.04% | +38.5% |
| Q3 2018 | $11,441,000 | +28.4% | 2,025,000 | 0.0% | 0.03% | +30.0% |
| Q2 2018 | $8,910,000 | -18.3% | 2,025,000 | +17.4% | 0.02% | -20.0% |
| Q1 2018 | $10,911,000 | +22.8% | 1,725,000 | 0.0% | 0.02% | +25.0% |
| Q4 2017 | $8,884,000 | -42.5% | 1,725,000 | 0.0% | 0.02% | -47.4% |
| Q3 2017 | $15,439,000 | – | 1,725,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|